Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade

European Journal of Pharmacology

Volumn 639, Issue 1-3, 2010, Pages 26-32

  Stefani, Mark R ^a   Moghaddam, Bita ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Addiction; Extradimensional shift; Perseveration; Prefrontal cortex; Response inhibition; Schizophrenia; Set shift

Indexed keywords

3 CYANO N (1,3 DIPHENYL 1H PYRAZOL 5 YL)BENZAMIDE; DIZOCILPINE; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; 3-CYANO-N-(1,3-DIPHENYL-1H-PYRAZOL-5-YL)BENZAMIDE; AMINO ACID RECEPTOR BLOCKING AGENT; BENZAMIDE DERIVATIVE; DIZOCILPINE MALEATE; METABOTROPIC RECEPTOR; PYRAZOLE DERIVATIVE;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HABITUATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; SCHIZOPHRENIA; TASK PERFORMANCE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COGNITION; COGNITION DISORDERS; DRUG EFFECTS; LEARNING; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALLOSTERIC REGULATION; ANIMALS; BENZAMIDES; COGNITION; COGNITION DISORDERS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; LEARNING; MALE; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; RECEPTOR, METABOTROPIC GLUTAMATE 5;

EID: 77953618942     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.01.028     Document Type: Article

References (52)

1. Ango F., Robbe D., Tu J.C., Xiao B., Worley P.F., Pin J.P., Bockaert J., Fagni L. Homer-dependent cell surface expression of metabotropic glutamate receptor type 5 in neurons. Mol. Cell. Neurosci. 2002, 20:323-329.
2. Aultman J.M., Moghaddam B. Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacologia 2001, 153:353-364.
3. Awad H., Hubert G.W., Smith Y., Levey A.I., Conn P.J. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J. Neurosci. 2000, 20:7871-7879.
4. Ayala J.E., Chen Y., Banko J.L., Shefflere D.J., Williams R., Telk A.N., Watson N.L., Xiang Z., Zhang Y., Jones P., Lindsley C.W., Olive M.F., Conn P.J. mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology 2009, 34:2057-2071.
5. Balschun D., Wetzel W. Inhibition of group I metabotropic glutamate receptors blocks spatial learning in rats. Neurosci. Lett. 1998, 249:41-44.
6. Balschun D., Zuschratter W., Wetzel W. Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory. Neuroscience 2006, 142:691-702.
7. Baude A., Nusser Z., Roberts J.D.B., Mulvihill E., McIlhinney R.A.J., Somogyi P. The metabotropic glutamate receptor (mGluR1a) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 1993, 11:771-787.
8. Besheer J., Grondin J.J., Sallling M.C., Spanos M., Stevenson R.A., Hodge C.W. Interoceptive effects of alcohol require mGlu5 receptor activity in the nucleus accumbens. J. Neurosci. 2009, 29:9582-9591.
9. Birrell J.M., Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci. 2000, 20:4320-4324.
10. Bleakman D., Rusin K.I., Chard P.S., Glaum S.R., Miller R.J. Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn. Mol. Pharmacol. 1992, 42:192-196.
11. Bradbury M.J., Campbell U., Giracello D., Chapman D., King C., Tehrani L., Cosford N.D.P., Anderson J., Varney M.A., Strack A.M. Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice. J. Pharmacol. Exp. Ther. 2005, 313:395-402.
12. Carroll F.I. Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction. Ann. N. Y. Acad. Sci. 2008, 1141:221-232.
13. De Leonibus E., Managò F., Giordani F., Petrosino F., Lopez S., Oliverio A., Amalric M., Mele A. Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease. Neuropsychopharmacology 2009, 34:729-738.
14. Doherty A.J., Palmer M.J., Henley J.M., Collingridge G.L., Jane D.E. (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but not mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology 1997, 36:265-267.
15. Egerton A., Reid L., McKerchar C.E., Morris B.J., Pratt J.A. Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia. Psychopharmacology 2005, 179:77-84.
16. Fagni L., Worley P.F., Ango F. Homer as both a scaffold and transduction molecule. Sci. STKE 2002, re8- %R 10.1126/stke.2002.137.re8 2002.
17. Floresco S.B., Magyar O., Ghods-Sharifi S., Vexelman C., Tse M.T.L. Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology 2005, 31:297-309.
18. Hassel B., Dingledine R. Glutamate. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects 2006, 267-290. Academic Press, Amsterdam. G.J. Siegel, R.W. Albers, S.T. Brady, D.L. Price (Eds.).
19. Haut M.W., Cahill J., Cutlip W.D., Stevenson J.M., Makela E.H., Bloomfield S.M. On the nature of Wisconsin Card Sorting Test performance in schizophrenia. Psychiatry Res. 1996, 65:15-22.
20. Homayoun H., Stefani M.R., Adams B.W., Tamagan G.D., Moghaddam B. Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors and dopamine release. Neuropsychopharmacology 2004, 29:1259-1269.
21. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991, 148:1301-1308.
22. Jentsch J.D., Taylor J.R. Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology 2001, 24:66-74.
23. Kew J.N., Kemp J.A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl.) 2005, 179:4-29.
24. Kinney G.G., Burno M., Campbell U.C., Hernandez L.M., Rodriguez D., Bristow L.J., Conn P.J. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J. Pharmacol. Exp. Ther. 2003, 306:116-123.
25. Kinney G.G., O'Brien J.A., Lemaire W., Burno M., Bickel D.J., Clements M.K., Chen T.-B., Wisnoski D.D., Lindsley C.W., Tiller P.R., Smith S., Jacobson M.A., Sur C., Duggan M.E., Pettibone D.J., Conn P.J., Williams D.L. A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J. Pharmacol. Exp. Ther. 2005, 313:199-206.
26. Kotlinska J., Bochenski M. Pretreatment with group I metabotropic glutamate receptor antagonists attenuates lethality induced by acute cocaine overdose and expression of sensitization to hyperlocomotor effect of cocaine in mice. Neurotox. Res. 2009, 10.1007/s12640-009-9136-8.
27. Krystal J.H., Perry E.B.J., Gueorguieva R., Belger A., Madonick S.H., Abi-Dargham A., Cooper T.B., MacDougall L., Abi-Saab W., D'Souza D.C. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine. Arch. Gen. Psychiatry 2005, 62:985-995.
28. Lecourtier L., Homayoun H., Tamagnan G., Moghaddam B. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-methyl-d-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biol. Psychiatry 2007, 62:739-746.
29. Lindsley C.W., Wisnoski D.D., Leister W.H., O'Brien J.A., Lemaire W., Williams D.L., Burno M., Sur C., Kinney G.G., Pettibone D.J., Tiller P.R., Smith S., Duggan M.E., Hartman G.D., Conn P.J., Huff J.R. Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1, 3-Diphenyl-1H-pyrazol-5-yl)benzamides that potentiate receptor function in vivo. J. Med. Chem. 2004, 47:5825-5828.
30. Liu F., Grauer S., Kelley C., Navarra R., Graf R., Zhang G., Atkinson P.J., Popiolek M., Wantuch C., Khawaja X., Smith D., Olsen M., Kouranova E., Lai M., Pruthi F., Pulicicchio C., Day M., Gilbert A., Pausch M.H., Brandon N.J., Beyer C.E., Comery T.A., Logue S., Rosenzweig-Lipson S., Marquis K.L. ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities. J. Pharmacol. Exp. Ther. 2008, 327:827-839.
31. Luján R., Roberts J.D.B., Shigemoto R., Ohishi H., Somogyi P. Differential plasma distribution of metabotropic glutamate receptors mGluR1a, mGluR2 and mGluR5, relative to neurotransmitter release sites. J. Comp. Neuroanat. 1997, 13:219-241.
32. Manahan-Vaughn D., Braunewell K.-H. The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cereb. Cortex 2005, 15:1703-1713.
33. Marino M.J., Conn P.J. Direct and indirect modulation of the N-methyl d-aspartate receptor. Curr. Drug Targets CNS Neurol. Disord. 2002, 1:1-16.
34. Melendez R.I., Gregory M.L., Bardo M.T., Kalivas P.W. Impoverished rearing environment alters metabotropic glutamate receptor expression and function in the prefrontal cortex. Neuropsychopharmacology 2004, 29:1980-1987.
35. Milner B. Effects of different brain lesions on card-sorting, the role of the frontal lobes. Arch. Neurol. 1963, 9:90-100.
36. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003, 40:881-884.
37. Moghaddam B. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology (Berl) 2004, 174:39-44.
38. Packard M.G., Vecchioli S.F., Schroeder J.P., Gasbarri A. Task-dependent role for dorsal striatum metabotropic glutamate receptors in memory. Learn. Mem. 2001, 8:96-103.
39. Page M.E., Szeliga P., Gasparini F., Cryan J.F. Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents. Psychopharmacology 2005, 179:240-246.
40. Pin J.P., Acher F. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Curr. Drug Targets CNS Neurol. Disord. 2002, 1:297-317.
41. Ragozzino M.E., Detrick S., Kesner R.P. Involvement of the prelimbic-infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. J. Neurosci. 1999, 19:4585-4594.
42. Ragozzino M.E., Ragozzino K.E., Mizumori J.J.Y., Kesner R.P. Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning. Behav. Neurosci. 2002, 116:105-115.
43. Romano C., Sesma M.A., McDonald C.T., O'Malley K., Van den Pol A.N., Olney J.W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol. 1995, 355:455-469.
44. Semenova S., Markou A. The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task. Neuropharmacology 2007, 52:863-872.
45. Shepp B.E., Eimas P.D. Intradimensional and extradimensional shifts in the rat. J. Comp. Physiol. Psychol. 1964, 57:357-361.
46. Stefani M.R., Moghaddam B. Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats. Behav. Neurosci. 2005, 119:420-428.
47. Stefani M.R., Moghaddam B. Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum. J. Neurosci. 2006, 26:8810-8818.
48. Stefani M.R., Groth K., Moghaddam B. Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. Behav. Neurosci. 2003, 117:728-737.
49. Tamminga C.A. Schizophrenia and glutamatergic transmission. Crit. Rev. Neurobiol. 1998, 12:21-36.
50. Uslaner J.M., Parmentier-Batteur S., Flick R.B., Surles N.O., Lam J.S.H., McNaughton C.H., Jacobson M.A., Hutson P.H. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus. Neuropharmacology 2009, 57:531-538.
51. Vanderschuren L.J.M.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl.) 2000, 151:99-120.
52. Xu J., Zhu Y., Contractor A., Heinemann S.F. mGluR5 has a critical role in inhibitory learning. J. Neurosci. 2009, 29:3676-3684.